CRG’s Brian Englander sat down with Joe Catanese, CEO of Calyxo, to discuss the kidney stone market, his career, and how his team is working to change kidney stone treatment through its innovative technology, ultimately improving the quality of care for patients who suffer from kidney stones.
Brian Englander of CRG recently sat down with Joe Catanese, CEO of Calyxo, to discuss the evolving kidney stone market and how Calyxo’s innovative technology is improving patient care. Based in Pleasanton, California, Calyxo is a commercial-stage medical device company revolutionizing kidney stone removal procedures with its groundbreaking CVAC Aspiration System.
The CVAC system, the first steerable vacuum technology for kidney stone removal during ureteroscopy, simplifies the process by aspirating stone fragments after laser procedures. Since its FDA 510(k) clearance in May 2020, Calyxo has focused on increasing adoption of its technology and is preparing to launch its second-generation CVAC system in 2024.
CRG’s investment in Calyxo, made in January 2022 through Fund IV, supports the company’s mission to deliver better outcomes for kidney stone patients. Learn more about Calyxo’s innovative approach and Joe Catanese’s vision for the future in our full interview.
CRG’s Brian Englander sat down with Erik Timko, CEO of OrthAlign, to discuss the orthopedic surgery market, his career, and how his team is working to improve surgical outcomes for patients undergoing knee replacement and hip replacement surgeries.
